ROSEVILLE, Minn., July 28,
2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq:
CLXT), a plant-based synthetic biology company, today announced
that Michael A. Carr, Chief
Executive Officer, and Bill Koschak,
Chief Financial Officer, will present at the Canaccord Genuity
42nd Annual Growth Conference taking place August 8-11, 2022.
The presentation details are as follows:
Date: Thursday, August 11, 2022
Presentation Time: 1:00 p.m. ET
Webcast:
https://wsw.com/webcast/canaccord76/clxt/2481993
A webcast of the presentation will be available for viewing and
replay on the Investors section of Calyxt's website at
www.calyxt.com.
Management is also available for 1:1 meetings during the
conference. Conference attendees should reach out to the event
organizers or investors@calyxt.com to schedule.
About Calyxt:
Calyxt (Nasdaq: CLXT) is a plant-based synthetic biology
company. The Company leverages its proprietary PlantSpring™
technology platform to engineer plant metabolism to produce
innovative high value plant-based chemistries for use in customers'
materials and products. As plant-based solutions, the Company's
synthetic biology products can be used in helping customers meet
their sustainability targets and financial goals. Calyxt's
diversified offerings are primarily delivered through its
proprietary BioFactory™ production system. For more information,
visit www.calyxt.com.
PlantSpring, BioFactory, Plant Cell Matrix™, and the Calyxt logo
are trademarks of Calyxt, Inc. Any other trademarks belong to their
respective owners.
Contacts:
Calyxt Media
Contact:
|
Calyxt Investor
Relations Contact:
|
|
David Rosen/ John
Garabo/ Michael Barron
Argot
Partners
(212)
600-1902
media@calyxt.com
|
Kimberly Minarovich/
Cameron Willis
Argot
Partners
(212)
600-1902
investors@calyxt.com
|
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/calyxt-to-present-at-the-canaccord-genuity-42nd-annual-growth-conference-301594599.html
SOURCE Calyxt, Inc.